Natalizumab and central nervous system lymphoma: No clear association
- 1 September 2009
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 66 (3) , 261-262
- https://doi.org/10.1002/ana.21835
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Primary central nervous system lymphoma in a patient treated with natalizumabAnnals of Neurology, 2009
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009
- Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive MedicationsJournal of Neuropathology and Experimental Neurology, 2008
- Health‐related quality of life in multiple sclerosis: effects of natalizumabAnnals of Neurology, 2007
- Natalizumab reduces visual loss in patients with relapsing multiple sclerosisNeurology, 2007
- Primary CNS lymphomaNature Clinical Practice Neurology, 2007
- A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2006
- The continuing increase in the incidence of primary central nervous system non‐Hodgkin lymphomaCancer, 2002
- Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patientsJournal of Neuro-Oncology, 1994